Groundhog day – Investor’s Edition. Bought additional 10 shares of Kemira for 13,34 EUR per share as a maintenance purchase. These euros were essentially coming from CapMan’s freshly paid dividend (second part). Still nibbling away until price is more favourable. Kemira is quite solid and boring company with partial focus on water sector which I’ve tried to find entry into for quite some time now.
Mandatory maintenance purchase for the secondary portfolio. I’m not a huge fan of Kemira‘s current valuation but started to nibble on it anyway. Just a tiny purchase of 10 shares bought for 14,26 EUR per share. I’ll probably keep in nibbling on it with such tiny pieces until valuation is more favourable. Company itself is quite solid and boring so in that sense there’s not much to complain. Never managed to pull the trigger when it was trading our 10 EUR per share.
It has been really hard finding anything to buy. In an attempt to increase my pharma exposure I bought an entry position in AbbVie Inc. in the from of 20 shares bought for 107,99 USD per share. Let’s consider this as a maintenance purchase while waiting for better market conditions. Good enough company in good enough position with good enough valuation. Good enough in these markets.